Gentian Diagnostics ASA
GENT.OL
#9374
Rank
C$78.53 M
Marketcap
$5.09
Share price
3.08%
Change (1 day)
-6.08%
Change (1 year)

P/E ratio for Gentian Diagnostics ASA (GENT.OL)

P/E ratio as of December 2024 (TTM): 64.3

According to Gentian Diagnostics ASA's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 64.3286. At the end of 2023 the company had a P/E ratio of -60.1.

P/E ratio history for Gentian Diagnostics ASA from 2017 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2023-60.1124.44%
2022-26.8-40.08%
2021-44.7-7.28%
2020-48.2100.19%
2019-24.1-45.47%
2018-44.216.81%
2017-37.8-42.8%
2016-66.1

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.